Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

3 terminated/withdrawn out of 21 trials

Success Rate

76.9%

-9.6% vs industry average

Late-Stage Pipeline

67%

14 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
9(47.4%)
Phase 4
5(26.3%)
N/A
3(15.8%)
Phase 2
2(10.5%)
19Total
Phase 3(9)
Phase 4(5)
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT03075241Phase 3Completed

Z-Drugs for Sleep Disorders in Alzheimer's Disease

Role: lead

NCT02589314Terminated

Effect of Periodontal Therapy in the Systemic Status of Individuals With Chronic Periodontitis and Diabetes Type 2

Role: collaborator

NCT04291794Phase 4Unknown

Mean Arterial Pressure Reduction Anesthesia Induction Using Propofol Bolus or Tritiated Target-infusion

Role: lead

NCT04288466Not ApplicableUnknown

Gastric Emptying of Maltodextrin Solution in Elderly and in Adults

Role: lead

NCT02984618Not ApplicableTerminated

Sphenopalatine Block or Epidural Bloodpatch for Post Dural Puncture Headache: Randomized Controlled Trial

Role: lead

NCT03725228Phase 4Completed

Lidocaine Compared to Magnesium Sulfate to Prolong Spinal Anesthesia: Non-inferiority Randomized Clinical Trial

Role: lead

NCT03805282Phase 3Unknown

Intravenous Lidocaine to Supress of Cough Reflex During Anesthesia Emergence

Role: lead

NCT03171688Completed

Risk Factors for Nausea and Vomiting After Cesarean

Role: lead

NCT03595319Phase 4Unknown

Median Sevoflurane Concentration for Hypotension Between Young and Elderlypatients: Adaptive Clinical Trial

Role: lead

NCT03171740Phase 3Completed

Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children

Role: lead

NCT03280706Not ApplicableCompleted

Gastric Emptying During Labor at Term: Non-inferiority Clinical Trial

Role: lead

NCT03283410Phase 4Withdrawn

Determination of Propofol Target Concentration for Young and Elderly by Suppression Rate Analysis

Role: lead

NCT03065309Phase 3Completed

Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults

Role: lead

NCT03043157Phase 3Completed

Rocuronium Effective Dose for Laparoscopic Cholecystectomy

Role: lead

NCT02794779Phase 3Unknown

Minimum Oxytocin Dose for Cesarean During Labor: Adaptative Clinical Trial

Role: lead

NCT02454868Phase 4Completed

Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade

Role: lead

NCT01377974Phase 2Completed

Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis

Role: lead

NCT01655108Phase 3Unknown

Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients

Role: lead

NCT01528813Phase 2Unknown

Erbium-doped Yttrium Aluminium Garnet Laser(Er:Yag)Associated With Amorolfine Lacquer in the Treatment of Onychomycosis

Role: lead

NCT01867775Phase 3Unknown

Mirtazapine for Sleep Disorders in Alzheimer's Disease

Role: lead